These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5933846)

  • 1. [Contribution to the study on the resistance of tablets].
    Motycková S
    Cesk Farm; 1966 Feb; 15(2):94-7. PubMed ID: 5933846
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formation of tablets with the aid of chain extensiometry. II. Methodology of formulation].
    Delacourte-Thibaut A; Devise B; Guyot JC; Traisnel M
    J Pharm Belg; 1974; 29(6):489-522. PubMed ID: 4465436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in the production and control of tablets. 8. Methods for the evaluation of basic raw materials and semifinished products].
    Chalabala M; Malý J
    Cesk Farm; 1966 Jun; 15(5):264-8. PubMed ID: 5329646
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of content and uniformity of content of tablets prepared with a low concentration in active ingredient.
    Gayot A; Blouet E; Leterme P; Traisnel M
    Boll Chim Farm; 1988; 127(9-10):218-20. PubMed ID: 3248160
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the nature of the diluent, and the viscosity and binding concentration of the liquid moisturizer, on the characteristics of granules and tablets].
    Benkerrour L; Puisieux F; Duchêne D
    Pharm Acta Helv; 1982; 57(10-11):301-8. PubMed ID: 7146035
    [No Abstract]   [Full Text] [Related]  

  • 6. [Formulation of slow-release tablets. III. Lipid matrices].
    Doelker E; Buri P
    Pharm Acta Helv; 1981; 56(4-5):111-8. PubMed ID: 7255497
    [No Abstract]   [Full Text] [Related]  

  • 7. [Validity of Higuchi's Law in the case of tablets with a high concentration of active principle].
    Fessi H; Puisieux F; Marty JP; Carstensen JT
    Pharm Acta Helv; 1980; 55(10):261-9. PubMed ID: 7454733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tableting of difficult to activate solids. Binding conditions in calcium hydrogen phosphate tablets].
    Hütenrauch R; Fricke S
    Pharmazie; 1978 Jun; 33(6):376. PubMed ID: 684059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Applicability of the activation theory to the tabletting of polymorphic substances].
    Hüttenrauch R
    Pharmazie; 1983 Mar; 38(3):198-9. PubMed ID: 6867083
    [No Abstract]   [Full Text] [Related]  

  • 10. [Active ingredient release from solid drug forms--test methods, evaluation, influencing parameters].
    Knop K
    Pharm Unserer Zeit; 1999 Nov; 28(6):301-8. PubMed ID: 10614132
    [No Abstract]   [Full Text] [Related]  

  • 11. Compression properties of formulations containing matrix and drug.
    Chilamkurti RN; Rhodes CT; Schwartz JB
    Pharm Acta Helv; 1983; 58(5-6):146-52. PubMed ID: 6867048
    [No Abstract]   [Full Text] [Related]  

  • 12. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 13. [The preparation of dragees using pigment syrup].
    Speiser P
    J Pharm Belg; 1967; 22(9):329-53. PubMed ID: 5608933
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems posed by the formulation of tablets of a peptide extracted from Teskra echinops spinosus (Composees)].
    Pourrat A; Renoux R
    Ann Pharm Fr; 1976; 34(3-4):107-14. PubMed ID: 984679
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of granule size on the in vitro and in vivo properties of bendrofluazide tablets 5 mg.
    Rubinstein MH; Blane MC
    Pharm Acta Helv; 1977; 52(1-2):5-10. PubMed ID: 887643
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of tablet geometry to tablet strength].
    Hüttenrauch R; Jacob J
    Pharmazie; 1981 Oct; 36(10):712-3. PubMed ID: 7312930
    [No Abstract]   [Full Text] [Related]  

  • 17. [Industrial-scale experiments on powder mixing].
    Wayer M; Pap A; Kata M
    Acta Pharm Hung; 1980 Jan; 50(1):25-31. PubMed ID: 7361554
    [No Abstract]   [Full Text] [Related]  

  • 18. Mathematical evaluation of the dissolution of metronidazole from tablets.
    Deák D; Pintye-Hódi K; Szabó-Révész P; Kása P; Erós I; Muskó Z
    Pharmazie; 2000 May; 55(5):394-5. PubMed ID: 11828626
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of polymorphous transformations of sulfanilamide during table manufacture (author's transl)].
    Cruaud O; Duchêne D; Puisieux F; Chauvet A; Masse J
    J Pharm Belg; 1981; 36(1):15-20. PubMed ID: 7229900
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.